Skip to content

Treatment of biliary atresia and prevention of postoperative cholangitis with folic acid: Multicenter clinical study on drug efficacy

Therapeutic and preventive effect of Folic acid on billiary atresia and postoperative cholangitis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050992
Enrollment
Unknown
Registered
2021-09-10
Start date
2021-10-08
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary atresia

Interventions

control group:Conventional therapy
experimental group:Conventional therapy+Folic acid

Sponsors

Guangzhou Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: Two groups of participants will be recruited. 1.Patients diagnosed of highly suspected BA by experienced senior doctors. Inclusion criteria for this group: (1) Aged 0-90 days infants; (2) Cholangiography confirm biliary atresia; (3) Written informed consent from guardians; (4) Not accompanied by nervous system diseases such as epilepsy; (5) Without unexplained anemia; (6) Regular follow-up; 2. Post-Kasai Patients regular follow-up ongoing. Inclusion criteria for the second group: (1) 1-12months patients with BA; (2) Undergone surgery; (3) Written informed consent form guardians. (4) Without unexplained anemia; (5) Not accompanied by nervous system diseases such as epilepsy; (6) Without unexplained anemia; (7) Regular follow-up.

Exclusion criteria

Exclusion criteria: 1.Complications: Systemic inflammatory response syndrome or Multisystem malformation; 2.Unclear diagnosis of primary disease; 3.Unable to obtain parental authorization. 4.No operation was performed. 5.Unable to follow up in time. 6.Pernicious anemia.

Design outcomes

Primary

MeasureTime frame
Liver function indexes;Plasam folid acid level;iron level;microbiome;

Countries

China

Contacts

Public ContactZhang Yuxia

Guangzhou Women and Children Medical Center

yuxia.zhang@zhanglaboratory.com+86 18820412127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026